Serum biomarkers detection clusters improve the detection of symptomatic treatment effect in knee osteoarthitis patients: the results of a phase ib/iia study with the b2 receptor antagonist fasitibant

Authors :: Claudio Catalani
Cristina Rossi
Paola Cucchi
C.A. Maggi
Andrea Nizzardo
Francesca Bellucci
Stefania Meini
Angela Capriati
Source :: Osteoarthritis and Cartilage. 22
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: musculoskeletal diseases
medicine.medical_specialty
Pathology
business.industry
Symptomatic treatment
Antagonist
Biomedical Engineering
Gastroenterology
Fasitibant
B2 receptor
Rheumatology
Serum biomarkers
Internal medicine
medicine
Orthopedics and Sports Medicine
business

Full Text Access

Tools